Fatigue, neurological, and cognitive symptoms after COVID-19 - a nationwide matched cohort study in Denmark
Authors:
- Kristoffer Torp HansenKHKristoffer Torp Hansen
- Christina Bisgaard JensenCJChristina Bisgaard Jensen
- Rikke OvergaardRORikke Overgaard
- Stefan Nygaard HansenSHStefan Nygaard Hansen
- Charlotte Ulrikka RaskCRCharlotte Ulrikka Rask
- Per FinkPFPer Fink
- Henrik NielsenHNHenrik Nielsen
- Thomas Meinertz DantoftTDThomas Meinertz Dantoft
- Torben JørgensenTJTorben Jørgensen
- Sanne Møller ThysenSTSanne Møller Thysen
- Dorte RytterDRDorte Rytter
- Bodil Hammer BechBBBodil Hammer Bech
Open Access
- 12 June 2026
- journal article
- Published by Taylor & Francis in Infectious Diseases
- Vol. 58 (10) , 1-13
Abstract
To investigate if COVID-19 increases the odds of fatigue, headache, dizziness, concentration difficulties, and memory impairment as well as at least three of these symptoms, at 12 weeks after COVID-19. Additionally, we investigated whether symptoms were influenced by severity of COVID-19, sex, and pre-infection COVID-19 vaccination. This study utilised data from the DanishBiCoVac cohort and national registers. The BiCoVac cohort collected information about symptoms through four questionaries distributed between May 2021 and May 2022. Participants with COVID-19 were matched to participants without COVID-19.Three matching samples were created according to time since COVID-19. Logistic regression was performed for the association between COVID-19 and each outcome. Participants with COVID-19 within 0-4 weeks had higher odds of reporting all outcomes compared to participants without COVID-19. Between 4 and 12 weeks after COVID-19, the odds of symptoms were also higher, although attenuated. After 12 weeks, participants with COVID-19 also had higher odds of symptoms except for concentration difficulties compared to those without COVID-19. Odds for symptoms were highest for participants reporting severe infection. Prior COVID-19 vaccination might weaken the association while no clear modification was found for sex. Participants with COVID-19 had higher odds of all outcomes, especially within the first 4 weeks. After 12 weeks, the ORs were attenuated but still indicated an association for all outcomes except concentration difficulties. Individuals vaccinated against COVID-19 tended to report fewer symptoms after COVID-19. Participants with severe COVID-19 had the highest odds of symptoms.Keywords
Funding Information
- TrygFonden (153678)
- Danmarks Frie Forskningsfond (2034-00256B)
- TrygFonden
This publication has 30 references indexed in Scilit:
- Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccinationEuropean Journal of Epidemiology, 2025
- Post–COVID-19 Condition Fatigue Outcomes Among Danish ResidentsJAMA Network Open, 2024
- Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionJAMA Network Open, 2023
- The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysiseClinicalMedicine, 2022
- Prevalence and Correlates of Long COVID Symptoms Among US AdultsJAMA Network Open, 2022
- Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysisJournal of the Neurological Sciences, 2022
- Stress levels in high-school students after a semester of home-schoolingEuropean Child & Adolescent Psychiatry, 2021
- Examining the Whiteley Index-6 as a screener for DSM-5 presentations of severe health anxiety in primary careJournal of Psychosomatic Research, 2019
- A new questionnaire to identify bodily distress in primary care: The ‘BDS checklist’Journal of Psychosomatic Research, 2015
- One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disordersJournal of Psychosomatic Research, 2010